These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6671927)

  • 1. Activity of trimethoprim (TMP), sulphamethoxazole (SMX) and the combination against Bacteroides fragilis group isolates.
    Jackson-York GL; Gump BB; Gump DW
    J Antimicrob Chemother; 1983 Nov; 12(5):515-8. PubMed ID: 6671927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of sulfamethoxazole and trimethoprim against Bacteroides fragilis.
    Phillips I; Warren C
    Antimicrob Agents Chemother; 1976 May; 9(5):736-40. PubMed ID: 949171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of sulfamethoxazole trimethoprim against Bacteroides fragilis.
    Nadaud M
    Zentralbl Bakteriol Orig A; 1978 Nov; 242(1):79-84. PubMed ID: 735555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of activity of sulfamethoxazole and trimethoprim against anaerobic bacteria.
    Rosenblatt JE; Stewart PR
    Antimicrob Agents Chemother; 1974 Jul; 6(1):93-7. PubMed ID: 15828176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of enterococci to trimethoprim and trimethoprim-sulfamethoxazole.
    Crider SR; Colby SD
    Antimicrob Agents Chemother; 1985 Jan; 27(1):71-5. PubMed ID: 3920958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility of anaerobes to co-trimoxazole.
    Wüst J
    Infection; 1980; 8 Suppl 2():S187-9. PubMed ID: 7450860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of pleuropneumonia in pigs by in-feed medication with sulphadimethoxine and sulphamethoxazole in combination with trimethoprim.
    Mengelers MJ; Kuiper HA; Pijpers A; Verheijden JH; van Miert AS
    Vet Q; 2000 Jul; 22(3):157-62. PubMed ID: 10952447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of in vitro sensitivity testing methods of detecting sulphamethoxazole trimethoprim synergy. Correlation with mouse protection assay.
    Rawal BD; Cottis L
    Arzneimittelforschung; 1980; 30(7):1049-51. PubMed ID: 6998489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of highly trimethoprim-sulfamethoxazole-resistant Shigella in a native American population: an epidemiologic study.
    Griffin PM; Tauxe RV; Redd SC; Puhr ND; Hargrett-Bean N; Blake PA
    Am J Epidemiol; 1989 May; 129(5):1042-51. PubMed ID: 2650535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance among fecal flora of patients taking sulfamethoxazole-trimethoprim or trimethoprim alone.
    Guerrant RL; Wood SJ; Krongaard L; Reid RA; Hodge RH
    Antimicrob Agents Chemother; 1981 Jan; 19(1):33-8. PubMed ID: 7247360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low trimethoprim susceptibility of anaerobic bacteria due to insensitive dihydrofolate reductases.
    Then RL; Angehrn P
    Antimicrob Agents Chemother; 1979 Jan; 15(1):1-6. PubMed ID: 218496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure to demonstrate a consistent in vitro bactericidal effect of trimethoprim-sulfamethoxazole against enterococci.
    Najjar A; Murray BE
    Antimicrob Agents Chemother; 1987 May; 31(5):808-10. PubMed ID: 3111362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole.
    Murray BE; Rensimer ER; DuPont HL
    N Engl J Med; 1982 Jan; 306(3):130-5. PubMed ID: 7033781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Susceptibility of gram negative bacteria to TMP-SMX and ofloxacin].
    Unal S; Aydin M; Akin A
    Mikrobiyol Bul; 1988; 22(4):316-21. PubMed ID: 3266971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trimethoprim-resistant Enterobacteriaceae in urinary tract infection.
    Wong CK; Harding GK; Ronald AR; Hoban S
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):54-8. PubMed ID: 1093652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of trimethoprim and trimethoprim-sulfamethoxazole on development of drug-resistant vaginal and fecal floras.
    Pancoast SJ; Hyams DM; Neu HC
    Antimicrob Agents Chemother; 1980 Feb; 17(2):263-8. PubMed ID: 7387147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum and saliva concentrations of sulfamethoxazole and trimethoprim in adults and children: relation between saliva concentrations and in vitro activity against nasopharyngeal pathogens.
    Kamme C; Melander A; Nilsson NI
    Scand J Infect Dis; 1983; 15(1):107-13. PubMed ID: 6342125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combination of sulfamethoxazole, trimethoprim, and isoniazid or rifampin is bactericidal and prevents the emergence of drug resistance in Mycobacterium tuberculosis.
    Vilchèze C; Jacobs WR
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5142-8. PubMed ID: 22825115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined activity of sulfamethoxazole, trimethoprim, and polymyxin B against gram-negative bacilli.
    Rosenblatt JE; Stewart PR
    Antimicrob Agents Chemother; 1974 Jul; 6(1):84-92. PubMed ID: 15828175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity and interaction of trimethoprim and sulphamethoxazole against Escherichia coli.
    Greenwood D; O'Grady F
    J Clin Pathol; 1976 Feb; 29(2):162-6. PubMed ID: 777036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.